Israeli study finds fourth COVID-19 vaccine dose boosts antibodies five-fold, PM says -Breaking
[ad_1]
© Reuters. A doctor prepares the dose of COVID-19 vaccine. The second shot was approved by Israel for immunocompromised people aged over 60 and staff in Tel Aviv. It took place on January 3, 2022. REUTERS/Amir CohenJERUSALEM, (Reuters) – A fourth dose COVID-19 vaccine increases antibodies fivefold a week following administration, Israeli Prime Minister Naftali Bennett said Tuesday, citing preliminary Israeli findings.
Bennett stated that “a week into the fourth dosage we know to an even higher degree of certainty the safety of the fourth dose,” Sheba Medical Center’s Bennett spoke. The center is administering second booster shots as a trial for its employees amid the nationwide increase in Omicron variant infection.
He said, “The second piece is news: One week after administering a fourth dose of vaccines, we observe a fivefold increase in antibodies in the person vaccinated.”
Bennett stated in English that “this most likely means a substantial increase against infection,…hospitalisation, and (severe] symptoms.”
Israel is a leader in the study of COVID-19 vaccine effects. It was the country that rolled out the most COVID-19 inoculations in a short time span, and also the one to offer boosters for the third dose. Now, it is administering the fourth dose of BioNTech/Pfizer to seniors over 60 and healthcare workers as well as immunocompromised patients.
Fusion MediaFusion Media and anyone associated with it will not assume any responsibility for losses or damages arising from the use of this website’s data including quotes and charts. Trading the financial markets is one of most risky investment options. Please make sure you are fully aware about the costs and risks involved.
[ad_2]
